Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.

By P. Schuetz, Yannick Wirz, Ramon Sager, M. Christ-Crain, D. Stolz, M. Tamm, L. Bouadma, C. Luyt, M. Wolff, J. Chastre and 31 more. Cochrane Database of Systematic Reviews, 2017

653 citations recorded by the source corpus.

Subfields: Applied Microbiology and Biotechnology, Critical Care and Intensive Care Medicine, Epidemiology

View Paper: https://www.semanticscholar.org/paper/009acd5b8bce3991504b71ebd0c0101ba62f112f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. J. Bourbeau
2. G. Criner
3. N. Roche
4. Fernando J. Martinez
5. J. Wedzicha
6. L. Fabbri
7. M. Decramer
8. P. Barnes

Citations in the corpus

• Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. (2017, background): “One review reported that antibiotics reduce the risk of shortterm mortality by 77%, treatment failure by 53% and sputum purulence by 44%(275) Procalcitonin-guided antibiotic treatment may reduce antibiotic exposure and side effects with the same clinical efficacy.(276,277) A study in patients with e”